“Revolutionizing Pediatric Dermatology: Dupilumab’s Impact on Atopic Dermatitis in Kids” (2024) American Journal of Life Science and Innovation, 3(1), pp. 61–68. doi:10.54536/ajlsi.v3i1.2696.